APA (7th ed.) Citation

Joshua A. Jacobs, Alexander R. Zheutlin, Catherine G. Derington, Jordan B. King, Ambarish Pandey, & Adam P. Bress. (2024). Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020. Elsevier.

Chicago Style (17th ed.) Citation

Joshua A. Jacobs, Alexander R. Zheutlin, Catherine G. Derington, Jordan B. King, Ambarish Pandey, and Adam P. Bress. Glucagon-like Peptide-1 Receptor Agonist and Sodium-glucose Cotransporter 2 Inhibitor Use Among Adults with Diabetes Mellitus by Cardiovascular-kidney Disease Risk: National Health and Nutrition Examination Surveys, 2015-2020. Elsevier, 2024.

MLA (9th ed.) Citation

Joshua A. Jacobs, et al. Glucagon-like Peptide-1 Receptor Agonist and Sodium-glucose Cotransporter 2 Inhibitor Use Among Adults with Diabetes Mellitus by Cardiovascular-kidney Disease Risk: National Health and Nutrition Examination Surveys, 2015-2020. Elsevier, 2024.